In the rapidly evolving landscape of healthcare technology, AI-driven medical imaging and diagnostics have surged to the forefront, transforming how clinicians detect, analyze, and treat diseases. As ...
The In Vitro Diagnostics Business Outlook provides unique insights into IVD market opportunities by offering comprehensive data on market segments, company… Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE...
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company with a well-established laboratory services business and a therapeutic developm… EL MONTE, Calif.–(BUSINESS WI...
Insight Molecular Diagnostics (IMDX) is a precision diagnostics company with disruptive transplant technology and strong recent price momentum. IMDX has surged 158% over the past year and is trading a...
